Tag: Nityr

First approved by the FDA in 2002, nitisinone has proven essential for managing rare inherited disorders. For those seeking to know **what is another name for nitisinone**, it is primarily known by its brand names, Orfadin and Nityr, and by the brand Harliku for a specific condition.

With annual costs for nitisinone treatment potentially running into the hundreds of thousands of dollars, managing the financial aspect of this rare disease medication is a significant concern for patients. This article explores the factors influencing how much does nitisinone cost and outlines the various pathways for financial relief.

Nitisinone, originally developed as a herbicide, has dramatically changed the prognosis for patients with hereditary tyrosinemia type 1 since its first use in the 1990s. This article explores what is nitisinone used for, detailing its crucial role in managing specific rare metabolic disorders alongside necessary dietary adjustments.